Table 1.
Characteristics of 23 patients with radiopharmaceutical uptake in extraosseous neoplasms
| Characteristics | Value | Percentage (range) |
|---|---|---|
| Age (years) | 57.4 ± 12.1 | 33–78 |
| Sex | ||
| Male | 12 | 52.2% |
| Female | 11 | 47.8% |
| History of malignancy | ||
| Breast cancer | 7 | 30.4% |
| Lung cancer | 4 | 17.4% |
| Colorectal cancer | 3 | 13.0% |
| Ovarian tumor | 2 | 8.7% |
| Osteosarcoma | 2 | 8.7% |
| Gastric stromal tumor | 1 | 4.3% |
| Endometrial cancer | 1 | 4.3% |
| Thyroid cancer | 1 | 4.3% |
| Malignant teratoma | 1 | 4.3% |
| Hepatocellular cancinoma | 1 | 4.3% |
| Primary treatment | ||
| No treatment | 16 | 69.6% |
| Surgery + chemotherapy +RT | 3 | 13.0% |
| Surgery + chemotherapy | 4 | 17.4% |
RT radiotherapy